Accession Number: | 0001104659-20-004422 |
Date: | 2020-01-13 |
Issuer: | ADAPTIMMUNE THERAPEUTICS PLC (ADAP) |
Original Submission Date: |
TAYTON-MARTIN HELEN KATRINA
C/O ADAPTIMMUNE THERAPEUTICS PLC,
60 JUBILEE AVENUE, MILTON PARK
ABINGDON, X0 OX14 4RX
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
AMERICAN DEPOSITARY SHARES | 2020-01-13 | S | 50,000 | d | $4.00 | 0 | direct | ||
AMERICAN DEPOSITARY SHARES | 2020-01-13 | S | 50,000 | d | $5.00 | 0 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | the sales reported in this form 4 were effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on june 28, 2019. |
f2 | these adss were sold in multiple transactions at a price of $4.00. upon request, the reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the securities and exchange commission full information regarding the adss sold at this price in this footnote. |
f3 | these adss were sold in multiple transactions at a price of $5.00. upon request, the reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the securities and exchange commission full information regarding the adss sold at this price in this footnote. |